Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.08 – $0.18
51% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.7M | $15.8M | $17.2M | $16.1M | $18.1M | $20.3M | $33.6M | $49.0M |
| Cost of revenue | $5.5M | $5.4M | $5.8M | $5.0M | $6.2M | $8.1M | $19.9M | $31.9M |
| Gross profit | $10.2M | $10.4M | $11.3M | $11.1M | $11.9M | $12.2M | $13.7M | $17.1M |
| Gross margin | 64.9% | 65.8% | 66.1% | 69.0% | 65.8% | 60.0% | 40.7% | 35.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$377.6K | $155.7K | −$49.1K | −$359.6K | −$784.1K | −$1.6M | −$92.8K | $412.0K |
| EBITDA | −$253.7K | $319.4K | $974.5K | −$224.8K | −$559.3K | −$1.3M | $338.4K | $931.0K |
| Net income | −$817.1K | −$99.4K | $441.8K | −$572.5K | −$952.0K | −$1.8M | −$333.0K | $265.0K |
| Net margin | -5.2% | -0.6% | 2.6% | -3.5% | -5.2% | -8.7% | -1.0% | 0.5% |
| EPS (diluted) | -0.02 | -0.00 | 0.01 | -0.01 | -0.02 | -0.04 | -0.01 | -0.00 |
Annual figures · source: Financial Modeling Prep
HEALTHWAREHOUSE.COM
No one on the platform currently holds HEWA.
No tracked institution reports a position in HEWA as of their last filing.
| Execution date | Ratio |
|---|---|
| 2010-07-29 | 1-for-20reverse |
No one on the platform has traded HEWA yet.
| $3M |
| — |
| CVSICV Sciences, Inc. | $0.02 | +0.41% | $5M | — |
| DHBUFDelivra Health Brands Inc. | $0.07 | -9.69% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.2× sales vs its 0.4× historical median P/S.
Fair value ≈ $0.34 · price $0.13 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.